Capital Investment Advisors’s Boston Scientific BSX Stock Holding History

Capital Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$423K	Sell	9,904 -1,384	-12%	-$75.2K	0.01%	559
2026 Q1	$708K	Sell	11,288 -167	-1%	-$13.4K	0.01%	414
2025 Q4	$1.09M	Sell	11,455 -17	-0.1%	-$1.67K	0.02%	330
2025 Q3	$1.12M	Sell	11,472 -309	-3%	-$32K	0.02%	318
2025 Q2	$1.27M	Sell	11,781 -735	-6%	-$74.4K	0.02%	297
2025 Q1	$1.26M	Buy	12,516 +9,617	+332%	+$968K	0.02%	288
2024 Q4	$259K	Buy	2,899 +315	+12%	+$27.7K	0.01%	557
2024 Q3	$217K	Buy	+2,584	New	+$204K	﹤0.01%	601
2019 Q4	–	Sell	-5,120	Closed	-$208K	–	519
2019 Q3	$208K	Buy	5,120 +100	+2%	+$4.24K	0.01%	464
2019 Q2	$216K	Buy	+5,020	New	+$193K	0.01%	448
2018 Q4	–	Sell	-5,420	Closed	-$209K	–	478
2018 Q3	$209K	Buy	+5,420	New	+$189K	0.01%	452

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Investment Advisors's BSX Position: Q2 2026 in Review

Capital Investment Advisors reduced its Boston Scientific (BSX) stake by 12% in Q2 2026, selling an estimated $75.2K and leaving 9,904 shares worth $423K. The position accounts for 0.01% of the portfolio, ranked #559.

Capital Investment Advisors first reported a position in BSX in Q3 2018 and has held it in 11 quarters since. The position peaked at $1.27M in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Capital Investment Advisors held 9,904 shares of Boston Scientific worth $423K as of Q2 2026.
Capital Investment Advisors sold 1,384 Boston Scientific shares in Q2 2026, an estimated $75.2K.
Boston Scientific made up 0.01% of Capital Investment Advisors's portfolio in Q2 2026, its #559 holding.
Capital Investment Advisors first reported a position in Boston Scientific in Q3 2018 and has held it in 11 quarters since.
Capital Investment Advisors's Boston Scientific position peaked at $1.27M in Q2 2025.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Capital Investment Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.